"L'établissement est labélisé Lieu de Santé Sans Tabac (LSST)"

During the past decade, Hopital Sub-Urbain du Bouscat conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Sub-Urbain du Bouscat" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Sanofi-Synthelabo" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Sub-Urbain du Bouscat" are "Arthritis, Rheumatoid" (2 trials), "Bladder Disease" (1 trials), "Colorectal Cancer" (1 trials), "Digestive System Diseases" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Hopital Sub-Urbain du Bouscat" in a lesser frequency.

Most popular intervention types in "Hopital Sub-Urbain du Bouscat" are "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ablathermy" (1 trials), "Questionnaire" (1 trials), "Tofacitinib" (1 trials) and "blood sample" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Sub-Urbain du Bouscat" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Sub-Urbain du Bouscat". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hopital Sub-Urbain du Bouscat, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Sub-Urbain du Bouscat, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".